SHREDDEDAF
Reference
10 NOV / 26
Reference room/Supplements
Supplements / Creatine

Creatine: what the evidence actually supports

Creatine monohydrate has an unusually deep evidence base for a supplement. That does not make every product equivalent, every claimed benefit proven or every population equally studied.

Creatine
without hype
05

The evidence does not support treating creatine as a miracle powder. It supports a narrower, more useful conclusion: creatine monohydrate can improve capacity for repeated high-intensity work and can add to some resistance-training adaptations.

Bottom line

For generally healthy adults who resistance-train, creatine monohydrate is one of the best-supported ergogenic supplements. Average effects are modest, individual response varies, and an increase in lean mass is not automatically an equal increase in new muscle tissue.

Body composition: a real signal with a measurement caveat

A 2024 systematic review and meta-analysis of 12 studies in adults younger than 50 found that adding creatine to resistance training increased measured lean body mass by 1.14 kg versus resistance training alone. It also reported small reductions in body-fat percentage and fat mass. Because creatine changes intracellular water, measured lean mass cannot be read as pure contractile-muscle gain.

Older adults: strength is clearer than function

A 2026 three-level meta-analysis of 11 randomized trials in adults aged 60 and above found a small additional strength benefit when creatine was combined with resistance training (g=0.31; moderate certainty). Pooled effects on muscle mass and physical function were not statistically significant and were graded low or very-low certainty. The authors warned against extrapolating directly to frail, sarcopenic or functionally limited older adults.

Safety: do not collapse “studied” into “safe for everyone”

A 2026 systematic review of randomized trials found no difference in urea or estimated glomerular filtration rate between creatine and control groups, while calling for trials extending beyond one year. A separate 2025 analysis covering 685 creatine trials found no overall difference in participant-reported side-effect frequency versus placebo.

Those are reassuring signals for studied populations, mostly using creatine monohydrate. They do not establish safety for contaminated or multi-ingredient products, undisclosed doses, pregnancy, children, or people with kidney disease or other clinical constraints. The 2025 safety paper also disclosed multiple supplement-industry relationships; its scale is useful, but the conflicts belong in the interpretation.

Practical audit translation

Creatine remains its own product class. The audit questions are form, disclosed quantity, independent quality testing, unnecessary ingredients, claims and cost—scored separately. “Advanced creatine matrix” is not an evidence grade. No brand or seller has paid for this review, and there are no affiliate links on this page.

Dose and consistency before format

Creatine monohydrate is the default because it is the form most directly represented in the evidence base and is widely available. A loading phase can saturate stores faster, but it is not mandatory for a long-term user. A consistent maintenance intake reaches the same practical destination more gradually. The exact approach should account for body size, gastrointestinal tolerance and professional advice where health conditions are relevant.

Timing receives more marketing attention than it deserves. Taking creatine at a repeatable time and maintaining intake is usually more important than attaching it to a narrow pre- or post-workout window. A product that creates missed servings through poor taste, cost or inconvenience can be worse in practice than a simpler option.

What a buyer should actually compare

Start with active amount per serving, number of effective servings and price per 3–5 g—not price per scoop. Then check whether the exact product appears in a current certification directory if sport testing matters. “Micronised” can improve mixing; it does not establish superior muscle or strength outcomes. Branded raw material can improve traceability, but the premium still needs to be reasonable.

Flavour systems, gummies and blends add variables without changing the central evidence. A pre-workout containing creatine can work, but occasional use makes consistent intake harder. A protein powder with creatine reduces dosing flexibility for anyone already supplementing separately.

Expected outcomes and bad expectations

Creatine supports training capacity and can contribute to strength or lean-mass outcomes over time when paired with an effective programme. It is not an acute stimulant, fat burner or substitute for progressive resistance training. Early body-mass change can include water associated with greater creatine storage; that should not automatically be described as new contractile muscle or unwanted fat.

No-purchase option

A person who does not train for strength, power or repeated high-intensity performance may have a smaller reason to prioritise creatine. Someone already obtaining enough through an existing product should not stack another. If budget is limited, programme quality, food, sleep and basic equipment can deserve attention first.

Sport certification and ordinary buyers

Drug-tested athletes have a stronger reason to prioritise exact-product banned-substance certification. Recreational users still benefit from transparent labels and credible manufacturing controls, but they should not assume a sport logo makes the ingredient more effective. Certification reduces a category of product risk; it does not create a larger physiological response.

The update trigger is simple: formula, serving, manufacturing source, certification status or market changes. A brand reputation cannot permanently grandfather a product into a high score.

Practical checklist

  • Choose creatine monohydrate unless a different form has a specific evidence-based reason.
  • Compare cost per 3–5 g, not cost per scoop.
  • Check the exact product and market in the relevant certification directory.
  • Avoid accidental duplication through pre-workout or protein blends.
  • Judge progress through training performance and longer-term outcomes, not an acute sensation.

When to pause

Pregnancy, kidney disease, complex medication or unexplained symptoms require individual advice. A clean label and strong research base do not remove personal medical context. Stop treating “generally well studied” as universal clearance.

References

  1. Desai I et al. Creatine plus resistance training and body composition in adults under 50: systematic review and meta-analysis of 12 studies. PubMed 39074168.
  2. Yao L et al. Creatine plus resistance training in adults aged 60+: systematic review and three-level meta-analysis of 11 randomized trials. PubMed 42712402.
  3. Kalaitzidis RG et al. Creatine and kidney function: systematic review and meta-analysis of randomized trials. PubMed 42035842.
  4. Kreider RB et al. Side effects in 685 creatine trials and adverse-event reports; industry conflicts declared. PubMed 40198156.
  5. U.S. NIH Office of Dietary Supplements. Exercise and athletic-performance supplements fact sheet. Issuing authority.
Evidence grade — A− for the core performance use case: multiple randomized trials, meta-analyses and an authoritative evidence review support creatine monohydrate for high-intensity exercise and some training adaptations. The grade is not an A because outcomes and response vary, lean-mass measurement is imperfect, and long-term or higher-risk population data are thinner. Last checked 9 November 2026.
← Back to the reference room